Professor Cristin Print
Molecular Medicine and Pathology, The University of Auckland, NZ Cris graduated in Medicine from the University of Auckland in 1989 and began research while working as a house surgeon in Dunedin, NZ. A PhD in the University of Auckland led to a four-year postdoctoral fellowship in the Walter and Eliza Hall Institute in Melbourne, Australia before six years in Cambridge University, UK. While there he co-founded a genomics and bioinformatics company and in 2005 he returned to the University of Auckland where he leads a cross-disciplinary research team of clinicians, cell biologists and data scientists who use genomics, systems biology and bioinformatics to better understand human disease, especially cancer.
|
He leads the Genomics Into Medicine Strategic Research Initiative in Auckland and Chairs the Auckland Regional Biobank Scientific Advisory Board. He is Acting Chair of the NZ Institute of Environmental Science and Research (ESR) and one of the Principal Investigators of the Maurice Wilkins Centre and of the Genomics Aotearoa Rakeiora program. Previously, he served as President of the NZ Society for Oncology and was Director of the Bioinformatics Institute at the University of Auckland. His work focusses on translation of precision medicine research into practice, with focus on bridging inequities in cancer outcomes in partnership with Māori colleagues.
The Precision Oncology Research-Practice Continuum
Precision medicine technologies such as genomics serve whānau with cancer in two ways: by guiding current patient care, and by enhancing biological understanding of cancer in order to improve future patient care. In this talk, Cris will summarise research by his team and their collaborators that uses precision medicine technologies synergistically with traditional pathology to enhance future precision oncology. He will discuss his own team’s positive experiences partnering closely with Māori genomics leaders, clinical colleagues and industry experts across a range of cancers. His talk will raise questions about what we can do in New Zealand to support precision medicine research in parallel with precision medicine practice.
Precision medicine technologies such as genomics serve whānau with cancer in two ways: by guiding current patient care, and by enhancing biological understanding of cancer in order to improve future patient care. In this talk, Cris will summarise research by his team and their collaborators that uses precision medicine technologies synergistically with traditional pathology to enhance future precision oncology. He will discuss his own team’s positive experiences partnering closely with Māori genomics leaders, clinical colleagues and industry experts across a range of cancers. His talk will raise questions about what we can do in New Zealand to support precision medicine research in parallel with precision medicine practice.